Bioorganic and Medicinal Chemistry Letters p. 3029 - 3034 (1996)
Update date:2022-07-29
Topics:
Veenstra, Siem J.
Hauser, Kathleen
Schilling, Walter
Betschart, Claudia
Ofner, Silvio
CGP 49823 is a potent NK1 antagonist which is centrally active after oral administration. The SAR of the C-2 substituent was investigated with respect to the affinity to the NK1 receptor. A practical synthesis of CGP 49823, suitable for scale-up, was developed. The key-step, a tandem acyliminium ion cyclization/Ritter reaction, gave trans-2-benzyl-4-acetamido-piperidines with high diastereoselectivity.
View MoreHK Vast Medicinal Chemistry Int'l Group Limited(expird)
website:http://www.hkvast.com/
Contact:+86-15000309979
Address:NO.6,Lane 108,Qinzhou Road,Xuhui District,Shanghai
Hangzhou Taiyan Trading Co., Ltd(expird)
Contact:+86-13777583958
Address:NO.63, Xingyi Street, Xihu District, Hangzhou, Zhejiang, China
Chengdu Yunyi International Trade Co., Ltd
Contact:
Address:china
Beijing Cooperate Pharmaceutical Co.,Ltd
website:http://www.cooperate-pharm.com/
Contact:86-01060279497
Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
SuZhou Hua-Emy Chemical Import and Export Co., LTD.
Contact:+86-512-88804994; +86-512-88804550;
Address:710, Building B, International Trade Center, 12 Huanghelu, Changshu, Jiangsu,China
Doi:10.1021/jo961781i
(1997)Doi:10.1016/S0960-894X(97)00008-5
(1997)Doi:10.1002/jhet.5570330626
(1996)Doi:10.1021/ja01077a028
(1964)Doi:10.1248/cpb.45.53
(1997)Doi:10.1021/ja01101a038
(1953)
